Furthermore, the prognostic significance of RSK2 could also be verified by measuring the protein expression level of RSK2 by flow cytometry, western blotting, and immunohistochemistry staining on tumor and paracancerous normal tissues of breast cancer patients in conjunction with clinical information analysis. The gene discussed is RPS6KA3; the disease is breast carcinoma.